{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:19:52Z","timestamp":1787728792379,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["227515\/Z\/23\/Z"],"award-info":[{"award-number":["227515\/Z\/23\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jaclp.2024.01.004","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T06:29:13Z","timestamp":1706855353000},"page":"271-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effectiveness and Safety of Intravenous Medications for the Management of Acute Disturbance (Agitation and Other Escalating Behaviors): A Systematic Review of Prospective Interventional Studies"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3612-4003","authenticated-orcid":false,"given":"Megan","family":"Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9734-6539","authenticated-orcid":false,"given":"Matt","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9562-0174","authenticated-orcid":false,"given":"Alysha Naomi","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8779-1068","authenticated-orcid":false,"given":"Sotiris","family":"Posporelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaclp.2024.01.004_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.20299\/jpi.2018.008","article-title":"Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: de-escalation and rapid tranquillisation","volume":"14","author":"Patel","year":"2018","journal-title":"J\u00a0Psychiatr Intensive Care"},{"key":"10.1016\/j.jaclp.2024.01.004_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jemermed.2009.11.007","article-title":"Violence in the emergency department: a national survey of emergency medicine residents and attending physicians","volume":"40","author":"Behnam","year":"2011","journal-title":"J\u00a0Emerg Med [Internet"},{"key":"10.1016\/j.jaclp.2024.01.004_bib3","article-title":"Prevalence and risk factors of violence by psychiatric acute inpatients: a systematic review and meta-analysis","volume":"10","author":"Iozzino","year":"2015","journal-title":"PLoS One [Internet]"},{"key":"10.1016\/j.jaclp.2024.01.004_bib4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5811\/westjem.2017.4.33411","article-title":"Managing acute behavioural disturbances in the emergency department using the environment, policies and practices: a systematic review","volume":"18","author":"Weiland","year":"2017","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.jaclp.2024.01.004_bib5","article-title":"Frequency and consequences of violence and aggression towards employees in the German healthcare and welfare system: a cross-sectional study","volume":"2","author":"Schablon","year":"2012","journal-title":"BMJ Open [Internet]"},{"key":"10.1016\/j.jaclp.2024.01.004_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12913-017-1988-7","article-title":"A\u00a0descriptive survey study of violence management and priorities among psychiatric staff in mental health services, across seventeen european countries","volume":"17","author":"Cowman","year":"2017","journal-title":"BMC Health Serv Res [Internet]"},{"key":"10.1016\/j.jaclp.2024.01.004_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/15622975.2015.1132007","article-title":"Assessment and management of agitation in psychiatry: expert consensus","volume":"17","author":"Garriga","year":"2016","journal-title":"world J Biol psychiatry"},{"key":"10.1016\/j.jaclp.2024.01.004_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5811\/westjem.2011.9.6864","article-title":"Verbal de-escalation of the agitated patient: consensus statement of the American association for emergency psychiatry project BETA de-escalation workgroup","volume":"13","author":"Richmond","year":"2012","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.jaclp.2024.01.004_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1017\/S174264641200026X","article-title":"Current rapid tranquillisation documents in the UK: a review of the drugs recommended, their routes of administration and clinical parameters influencing their use","volume":"9","author":"Innes","year":"2013","journal-title":"J\u00a0Psychiatr Intensive Care"},{"key":"10.1016\/j.jaclp.2024.01.004_bib10","first-page":"9","article-title":"Guidelines for the management of excited delirium\/acute behavioural disturbance (ABD)","author":"Gillings","year":"2016","journal-title":"R Coll Emerg Med Best Pract Guid"},{"key":"10.1016\/j.jaclp.2024.01.004_bib11","series-title":"Maudsley Prescribing Guidelines in Psychiatry","first-page":"937","article-title":"Intravenous formulations in psychiatry","author":"Taylor","year":"2021"},{"key":"10.1016\/j.jaclp.2024.01.004_bib12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.35652\/IGJPS.2012.47","article-title":"Alternative routes of drug administration-transdermal, pulmonary & parenteral","volume":"2","author":"Kwatra","year":"2012","journal-title":"Indo Glob J Pharm Sci"},{"key":"10.1016\/j.jaclp.2024.01.004_bib13","series-title":"Study quality assessment tools. Quality assessment of controlled intervention studies. Bethesda, Maryland Natl Hear Lung","author":"Blood Institute","year":"2020"},{"key":"10.1016\/j.jaclp.2024.01.004_bib14","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ [Internet]"},{"key":"10.1016\/j.jaclp.2024.01.004_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0736-4679(96)00259-4","article-title":"The efficacy of intravenous droperidol in the prehospital setting","volume":"15","author":"Rosen","year":"1997","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.jaclp.2024.01.004_bib16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00005053-197704000-00008","article-title":"Droperidol in acutely agitated patients: a double blind placebo-controlled study","volume":"164","author":"Van Leeuwen","year":"1977","journal-title":"J\u00a0Nerv Ment Dis"},{"key":"10.1016\/j.jaclp.2024.01.004_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annemergmed.2005.07.003","article-title":"Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department","volume":"47","author":"Knott","year":"2006","journal-title":"Ann Emerg Med [Internet]"},{"key":"10.1016\/j.jaclp.2024.01.004_bib18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.annemergmed.2016.07.033","article-title":"Midazolam-droperidol, droperidol, or olanzapine for acute agitation: a randomized clinical trial","volume":"69","author":"Taylor","year":"2017","journal-title":"Ann Emerg Med [Internet]"},{"key":"10.1016\/j.jaclp.2024.01.004_bib19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.annemergmed.2012.07.118","article-title":"Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"61","author":"Chan","year":"2013","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaclp.2024.01.004_bib20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0736-4679(98)00045-6","article-title":"Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol","volume":"16","author":"Richards","year":"1998","journal-title":"J\u00a0Emerg Med [Internet]"},{"key":"10.1016\/j.jaclp.2024.01.004_bib21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0196-0644(05)82660-5","article-title":"Droperidol versus haloperidol for chemical restraint of agitated and combative patients","volume":"21","author":"Thomas","year":"1992","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaclp.2024.01.004_bib22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S1470-2045(20)30307-7","article-title":"Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial","volume":"21","author":"Hui","year":"2020","journal-title":"Lancet Oncol [Internet]"},{"key":"10.1016\/j.jaclp.2024.01.004_bib23","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.3889\/oamjms.2019.676","article-title":"Sodium valproate versus continuous infusion of haloperidol in management of agitated critically Ill patients","volume":"7","author":"Khalil","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.jaclp.2024.01.004_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ajem.2020.04.013","article-title":"Efficacy of ketamine for initial control of acute agitation in the emergency department: a randomized study","volume":"44","author":"Lin","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jaclp.2024.01.004_bib25","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/CCM.0000000000001622","article-title":"Dexmedetomidine for the treatment of hyperactive delirium refractory to haloperidol in nonintubated ICU patients: a nonrandomized controlled trial","volume":"44","author":"Carrasco","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jaclp.2024.01.004_bib26","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/jama.2017.11468","article-title":"Effect of lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care: a randomized clinical trial","volume":"318","author":"Hui","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jaclp.2024.01.004_bib27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1742-6723.2008.01066.x","article-title":"Safety and effectiveness of high-dose midazolam for severe behavioural disturbance in an emergency department with suspected psychostimulant-affected patients","volume":"20","author":"Spain","year":"2008","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.jaclp.2024.01.004_bib28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/emermed-2011-200849","article-title":"Dexmedetomidine in the emergency department: assessing safety and effectiveness in difficult-to-sedate acute behavioural disturbance","volume":"29","author":"Calver","year":"2012","journal-title":"Emerg Med J"},{"key":"10.1016\/j.jaclp.2024.01.004_bib29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/YIC.0000000000000064","article-title":"Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial","volume":"30","author":"Asadollahi","year":"2015","journal-title":"Int Clin Psychopharmacol [Internet]"},{"key":"10.1016\/j.jaclp.2024.01.004_bib30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.psym.2020.04.017","article-title":"Anti-NMDAR encephalitis: a multidisciplinary approach to identification of the disorder and management of psychiatric Symptoms","volume":"61","author":"Forrester","year":"2020","journal-title":"Psychosomatics [Internet]"},{"key":"10.1016\/j.jaclp.2024.01.004_bib31","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/emp2.12138","article-title":"Improving the management of acutely agitated patients in the emergency department through implementation of Project BETA (Best practices in the evaluation and treatment of agitation)","volume":"1","author":"Roppolo","year":"2020","journal-title":"J\u00a0Am Coll Emerg Physicians Open"},{"key":"10.1016\/j.jaclp.2024.01.004_bib32","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/bcp.12272","article-title":"High dose droperidol and QT prolongation: analysis of continuous 12-lead recordings","volume":"77","author":"Calver","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaclp.2024.01.004_bib33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1067\/mem.2003.110","article-title":"Droperidol, QT prolongation, and sudden death: what is the evidence?","volume":"41","author":"Kao","year":"2003","journal-title":"Ann Emerg Med [Internet"},{"key":"10.1016\/j.jaclp.2024.01.004_bib34","article-title":"Droperidol for psychosis-induced aggression or agitation","volume":"12","author":"Khokhar","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaclp.2024.01.004_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/acem.12842","article-title":"A\u00a0large retrospective cohort of patients receiving intravenous olanzapine in the emergency department","volume":"23","author":"Martel","year":"2016","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jaclp.2024.01.004_bib36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.genhosppsych.2020.08.008","article-title":"Intravenous haloperidol: a systematic review of side effects and recommendations for clinical use","volume":"67","author":"Beach","year":"2020","journal-title":"Gen Hosp Psychiatry [Internet]"},{"key":"10.1016\/j.jaclp.2024.01.004_bib37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eurpsy.2004.05.006","article-title":"Rapid tranquilization: new approaches in the emergency treatment of behavioral disturbances","volume":"19","author":"De Fruyt","year":"2004","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.jaclp.2024.01.004_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40801-019-00161-y","article-title":"Serious cardiovascular adverse events reported with intravenous sedatives: a retrospective analysis of the MedWatch adverse event reporting system","volume":"6","author":"Duprey","year":"2019","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.jaclp.2024.01.004_bib39","first-page":"103","article-title":"Economic evaluation of dexmedetomidine relative to midazolam for sedation in the intensive care unit","volume":"65","author":"Lachaine","year":"2012","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.jaclp.2024.01.004_bib40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jemermed.2018.07.017","article-title":"Ketamine for rapid sedation of agitated patients in the prehospital and emergency department settings: a systematic review and proportional meta-analysis","volume":"55","author":"Mankowitz","year":"2018","journal-title":"J\u00a0Emerg Med [Internet"},{"key":"10.1016\/j.jaclp.2024.01.004_bib41","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ajem.2019.11.007","article-title":"Ketamine for emergency sedation of agitated patients: a systematic review and meta-analysis","volume":"38","author":"Sullivan","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jaclp.2024.01.004_bib42","article-title":"Valproate preparations for agitation in dementia","volume":"3","author":"Lonergan","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaclp.2024.01.004_bib44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5811\/westjem.2011.9.6866","article-title":"The psychopharmacology of agitation: consensus statement of the American association for emergency psychiatry project Beta psychopharmacology workgroup","volume":"13","author":"Wilson","year":"2012","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.jaclp.2024.01.004_bib45","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1056\/NEJMoa1808217","article-title":"Haloperidol and ziprasidone for treatment of delirium in critical\u00a0illness","volume":"379","author":"Girard","year":"2018","journal-title":"N\u00a0Engl J Med [Internet]"},{"key":"10.1016\/j.jaclp.2024.01.004_bib46","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa2211868","article-title":"Haloperidol for the treatment of delirium in ICU patients","volume":"387","author":"Andersen-Ranberg","year":"2022","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296024000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296024000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T03:02:17Z","timestamp":1718593337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667296024000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2667296024000120"],"URL":"https:\/\/doi.org\/10.1016\/j.jaclp.2024.01.004","relation":{},"ISSN":["2667-2960"],"issn-type":[{"value":"2667-2960","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and Safety of Intravenous Medications for the Management of Acute Disturbance (Agitation and Other Escalating Behaviors): A Systematic Review of Prospective Interventional Studies","name":"articletitle","label":"Article Title"},{"value":"Journal of the Academy of Consultation-Liaison Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaclp.2024.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of Academy of Consultation-Liaison Psychiatry.","name":"copyright","label":"Copyright"}]}}